Eli Lilly’s GLP-1 pill, orforglipron, shows promising trial results for weight loss and type 2 diabetes. Global regulatory approval is planned for 2025.
New GLP-1 pill for weight loss may be closer to reality as drugmaker Eli Lilly says it will file for regulatory approval
Related Posts
-
See a closer look at Taylor Swift’s massive diamond engagement ring
Taylor Swift and Travis Kelce are engaged! Check out all the details on her engagement…
-
Democrats demand Trump resume a nearly completed major wind project near Rhode Island
Power from the farm would cost 9.8 cents per kilowatt-hour, locked in for 20 years.…
-
A US tariff exemption for small orders ends Friday. It’s a big deal to some shoppers and businesses
Low-value imports lose duty-free status in the U.S., impacting small businesses, online shoppers and global…
-
Iowa deputy arrested for OWI after traffic stop: Sheriff’s office
JOHNSON COUNTY, Iowa — An Iowa deputy faces an OWI charge after a traffic stop…
Leave a Reply